Quick highlights
- Tumor marker primarily for monitoring, not screening
- Trend tracking is more useful than single readings
- Smoking and benign inflammation can raise CEA
- Interpreted with imaging and oncology care plan
- No fasting usually required
- Useful for treatment response monitoring when marker is relevant
- Avoids alarmism; emphasizes limitations and context
- Home blood collection available in many service areas
- Clear advice to disclose smoking status for interpretation
- SEO coverage: CEA test, carcinoembryonic antigen test, colorectal cancer marker monitoring
What’s included
Preparation
- Book blood draw (home or lab)
- No fasting unless combined tests require fasting
- Disclose smoking status and cessation timing
- Inform clinician about recent infections/inflammation
- Collect serum blood sample via trained phlebotomist
- Download report from <a href='/my-account/'>View reports</a>
- Review trends with oncologist; do not interpret single value alone
- Follow clinician plan for imaging and follow-up
FAQs
A tumor marker that may be used for monitoring certain cancers, especially colorectal, when clinically indicated.
No. It is not recommended for routine cancer screening in healthy individuals.
Usually no.
Yes, smokers can have higher baseline CEA; disclose smoking status for interpretation.
No. CEA is not diagnostic and can rise in benign conditions; clinicians interpret with imaging and history.
To monitor trends and treatment response over time.
Often same day or within 24 hours.
Serum blood sample.
Yes in many serviceable areas.
Inflammation, liver disease, and other non-cancer conditions may affect levels; clinician interpretation is required.
Commonly colorectal; other uses depend on tumor type and clinician plan.
Discuss with your clinician; trends and context matter.
Download from <a href='/my-account/'>View reports</a>.
No. Treatment decisions rely on the full clinical picture and imaging.
Notes
CEA levels may be elevated in smokers and benign disease.
